172 related articles for article (PubMed ID: 19834547)
1. Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.
Kuwahara A; Yamamori M; Nishiguchi K; Okuno T; Chayahara N; Miki I; Tamura T; Inokuma T; Takemoto Y; Nakamura T; Kataoka K; Sakaeda T
Int J Med Sci; 2009 Sep; 6(6):305-11. PubMed ID: 19834547
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for Japanese stage II-IV esophageal cancer compared with cisplatin plus 5-fluorouracil regimen: a retrospective study.
Yamashita H; Nakagawa K; Tago M; Igaki H; Nakamura N; Shiraishi K; Sasano N; Ohtomo K
Dis Esophagus; 2006; 19(1):15-9. PubMed ID: 16364038
[TBL] [Abstract][Full Text] [Related]
3. Effect of dose-escalation of 5-fluorouracil on circadian variability of its pharmacokinetics in Japanese patients with Stage III/IVa esophageal squamous cell carcinoma.
Kuwahara A; Yamamori M; Nishiguchi K; Okuno T; Chayahara N; Miki I; Tamura T; Kadoyama K; Inokuma T; Takemoto Y; Nakamura T; Kataoka K; Sakaeda T
Int J Med Sci; 2010 Jan; 7(1):48-54. PubMed ID: 20151048
[TBL] [Abstract][Full Text] [Related]
4. Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.
Kuwahara A; Yamamori M; Kadoyama K; Nishiguchi K; Nakamura T; Miki I; Tamura T; Okuno T; Omatsu H; Sakaeda T
J Exp Clin Cancer Res; 2011 Oct; 30(1):94. PubMed ID: 21970688
[TBL] [Abstract][Full Text] [Related]
5. VEGF -634C/G genotype is predictive of long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.
Tamura T; Kuwahara A; Yamamori M; Nishiguchi K; Nakamura T; Okuno T; Miki I; Manabe Y; Sakaeda T
Int J Med Sci; 2012; 9(10):833-7. PubMed ID: 23155356
[TBL] [Abstract][Full Text] [Related]
6. TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.
Kuwahara A; Yamamori M; Fujita M; Okuno T; Tamura T; Kadoyama K; Okamura N; Nakamura T; Sakaeda T
J Exp Clin Cancer Res; 2010 Jul; 29(1):100. PubMed ID: 20646319
[TBL] [Abstract][Full Text] [Related]
7. [Concurrent chemoradiotherapy with nedaplatin and 5-fluorouracil (5-fu) for locally advanced squamous cell carcinoma of the esophagus].
Kubo N; Morimoto J; Tanaka H; Ohira M; Noda E; Amano R; Inoue T; Yamada N; Yashiro M; Maeda K; Yamashita Y; Muguruma K; Sawada T; Hirakawa K
Gan To Kagaku Ryoho; 2009 Nov; 36(12):1997-9. PubMed ID: 20037303
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer.
Yamashita H; Haga A; Takenaka R; Kiritoshi T; Okuma K; Ohtomo K; Nakagawa K
Radiat Oncol; 2016 Jan; 11():4. PubMed ID: 26781439
[TBL] [Abstract][Full Text] [Related]
9. Nedaplatin concurrent with three-dimensional conformal radiotherapy for treatment of locally advanced esophageal carcinoma.
Shen ZT; Wu XH; Li B; Shen JS; Wang Z; Li J; Zhu XX
World J Gastroenterol; 2013 Dec; 19(48):9447-52. PubMed ID: 24409075
[TBL] [Abstract][Full Text] [Related]
10. [A case of advanced esophageal cancer with multiple lymph node metastases successfully treated with induction chemotherapy consisting of nedaplatin and 5-FU followed by chemoradiotherapy].
Sasaki T; Nakamura K; Toba T; Kimura M; Ohga S; Urashima Y; Terashima H; Masuda K
Gan To Kagaku Ryoho; 2002 Aug; 29(8):1417-20. PubMed ID: 12214470
[TBL] [Abstract][Full Text] [Related]
11. Enhanced antitumor efficacy of nedaplatin with 5-fluorouracil against human squamous carcinoma xenografts.
Takeda Y; Kasai H; Uchida N; Yoshida H; Maekawa R; Sugita K; Yoshioka T
Anticancer Res; 1999; 19(5B):4059-64. PubMed ID: 10628354
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
[TBL] [Abstract][Full Text] [Related]
13. Single-institute phase I/II trial of alternating chemoradiotherapy with 5-FU and nedaplatin for esophageal carcinoma.
Kodaira T; Fuwa N; Kamata M; Furutani K; Tachibana H; Yamazaki T
Anticancer Res; 2006; 26(1B):471-8. PubMed ID: 16739307
[TBL] [Abstract][Full Text] [Related]
14. A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer.
Nakajima TE; Ura T; Ito Y; Kato K; Minashi K; Nihei K; Hironaka S; Boku N; Kagami Y; Muro K
Jpn J Clin Oncol; 2009 Jan; 39(1):37-42. PubMed ID: 19103671
[TBL] [Abstract][Full Text] [Related]
15. Phase I trial of escalating-dose cisplatin with 5-fluorouracil and concurrent radiotherapy in Chinese patients with esophageal cancer.
Lin Q; Gao XS; Qiao XY; Zhou ZG; Zhang P; Chen K; Zhao YN; Asaumi J
Acta Med Okayama; 2008 Feb; 62(1):37-44. PubMed ID: 18323870
[TBL] [Abstract][Full Text] [Related]
16. [Cost effectiveness of chemoradiotherapy with cisplatin/fluorouracil and nedaplatin/fluorouracil for patients with esophageal cancer].
Tomura K; Kogo M; Inoue T; Kaneko K; Imawari M; Yoneyama K; Kiuchi Y
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1807-13. PubMed ID: 18030014
[TBL] [Abstract][Full Text] [Related]
17. [Phase II multicenter clinical trial of nedaplatin in the treatment of malignant tumors].
Zhang P; Feng FY; Wu LY; Hu Y; Liu JW; Gao YJ; Guan XQ; Nan KJ; Suo AL; Wang XW; Zhang MH; Zhang WD; Li CW; Zhang Y; Zhao JB
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):230-4. PubMed ID: 16875614
[TBL] [Abstract][Full Text] [Related]
18. [A case of local advanced cervical esophageal cancer treated with concurrent radiochemotherapy followed by surgery].
Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Takakita S; Kusumi F; Kato Y; Takeda H
Gan To Kagaku Ryoho; 1997 Oct; 24(13):2001-4. PubMed ID: 9350249
[TBL] [Abstract][Full Text] [Related]
19. Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer.
Shiozaki A; Yamagishi H; Itoi H; Fujiwara H; Kikuchi S; Okamoto K; Ichikawa D; Fuji N; Ochiai T; Sonoyama T; Ueda Y
Oncol Rep; 2005 Apr; 13(4):667-72. PubMed ID: 15756440
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study of the combination of small amount of nedaplatin (CDGP)/5-FU with radiation for the treatment of esophageal cancer].
Inaba H; Tsuda T; Miyazaki A; Watanabe Y; Nakaya S; Koitabashi Y; Ogihara K; Hara T; Kato N; Kobayashi Y; Nakagawa T; Kitajima S; Endo T; Iino S; Hoshikawa Y
Nihon Shokakibyo Gakkai Zasshi; 2002 Oct; 99(10):1191-6. PubMed ID: 12415854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
